Predicting Major Bleeding in Patients With Noncardioembolic Stroke on Antiplatelets

Neurology - United States
doi 10.1212/wnl.0000000000004289
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

P6584Impact of Cancer on Major Bleeding and Stroke in Patients Using Direct Oral Anticoagulants

European Heart Journal
Cardiovascular MedicineCardiology
2018English

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2014English

Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants

Journal of Medical Economics
Health Policy
2019English

Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes

JAMA - Journal of the American Medical Association
Medicine
2012English

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies

Frontiers in Medicine
Medicine
2020English

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation

JAMA network open
Medicine
2020English

Incidence of Major Bleeding Complication of Warfarin Therapy in Japanese Patients With Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Mild Renal Disease Increases Major Bleeding in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Stenting

Thrombosis and Haemostasis
Hematology
2012English

Characteristics, Management, and Outcomes of Patients With Atrial Fibrillation Experiencing a Major Bleeding Event While on Rivaroxaban

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy